Allianz Asset Management’s Apellis Pharmaceuticals APLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,800
| Closed | -$411K | – | 1535 |
|
|
2025
Q1 | $411K | Hold |
18,800
| – | – | ﹤0.01% | 1478 |
|
|
2024
Q4 | $600K | Buy |
18,800
+11,400
| +154% | +$364K | ﹤0.01% | 1358 |
|
|
2024
Q3 | $213K | Sell |
7,400
-6,200
| -46% | -$179K | ﹤0.01% | 1607 |
|
|
2024
Q2 | $522K | Hold |
13,600
| – | – | ﹤0.01% | 1407 |
|
|
2024
Q1 | $799K | Hold |
13,600
| – | – | ﹤0.01% | 1307 |
|
|
2023
Q4 | $814K | Hold |
13,600
| – | – | ﹤0.01% | 1281 |
|
|
2023
Q3 | $517K | Sell |
13,600
-9,000
| -40% | -$342K | ﹤0.01% | 1436 |
|
|
2023
Q2 | $2.06M | Buy |
22,600
+4,600
| +26% | +$419K | ﹤0.01% | 993 |
|
|
2023
Q1 | $1.19M | Buy |
+18,000
| New | +$1.19M | ﹤0.01% | 1223 |
|
|
2022
Q4 | – | Sell |
-11,000
| Closed | -$751K | – | 1488 |
|
|
2022
Q3 | $751K | Sell |
11,000
-44,140
| -80% | -$3.01M | ﹤0.01% | 1252 |
|
|
2022
Q2 | $2.49M | Buy |
55,140
+22,590
| +69% | +$1.02M | ﹤0.01% | 1240 |
|
|
2022
Q1 | $1.65M | Buy |
32,550
+3,200
| +11% | +$163K | ﹤0.01% | 1419 |
|
|
2021
Q4 | $1.39M | Buy |
+29,350
| New | +$1.39M | ﹤0.01% | 1504 |
|
|
2021
Q3 | – | Sell |
-26,240
| Closed | -$1.66M | – | 2017 |
|
|
2021
Q2 | $1.66M | Buy |
26,240
+20,940
| +395% | +$1.32M | ﹤0.01% | 1345 |
|
|
2021
Q1 | $227K | Hold |
5,300
| – | – | ﹤0.01% | 1835 |
|
|
2020
Q4 | $303K | Sell |
5,300
-18,820
| -78% | -$1.08M | ﹤0.01% | 1722 |
|
|
2020
Q3 | $728K | Sell |
24,120
-2,102
| -8% | -$63.4K | ﹤0.01% | 1494 |
|
|
2020
Q2 | $857K | Sell |
26,222
-1,900
| -7% | -$62.1K | ﹤0.01% | 1453 |
|
|
2020
Q1 | $753K | Sell |
28,122
-2,482
| -8% | -$66.5K | ﹤0.01% | 1524 |
|
|
2019
Q4 | $937K | Buy |
+30,604
| New | +$937K | ﹤0.01% | 1749 |
|